EP3630177
Meðhöndlunarviðmið fyrir samsetta and-CD19 mótefnis og venetóklax meðhöndlun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.5.2018EP published:
9.8.2023EP application number:
18728153.0
EP translation filed:
16.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
29.5.2038Expiry date:
29.5.2026Next due date:
31.5.2026
Title in English:
TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENTLanguage of the patent:
English
Timeline
Today
30.5.2018EP application
9.8.2023EP Publication
16.10.2023Translation submitted
15.11.2023Registration published
29.5.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Inventor
Name:
KELEMEN, PeterAddress:
82152 Planegg, DE
Name:
SCHWARZ, MichaelAddress:
82152 Planegg, DE
Name:
WINDERLICH, MarkAddress:
82152 Planegg, DE
Name:
HEEGER, SteffenAddress:
68165 Mannheim, DE
Name:
WEINELT, DominikaAddress:
82152 Planegg, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17173712Date:
31.5.2017Country:
EP
Classification
Categories:
A61K 39/395, A61K 31/00, C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 23.5.2024
Expires: 29.5.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 30.5.2025
Expires: 29.5.2026
Payer: Árnason Faktor ehf.